Current treatments for infection in neutropenic patients with heamtologic malignancy

ONCOLOGY

Volumn 14, Issue 8 SUPPL. 6, 2000, Pages 31-34

  Greene, John N ^a   Linch, David C ^b   Miller, Carole B ^c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BLOOD DISEASE; CROSS INFECTION; DRUG COMBINATION; HUMAN; INFECTION CONTROL; METHODOLOGY; NEUTROPENIA; REVIEW; RISK FACTOR; TIME;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; HUMANS; INFECTION CONTROL; NEUTROPENIA; RISK FACTORS; TIME FACTORS;

EID: 0034240998     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. NCCN Practice Guidelines for Fever and Neutropenia, Version 1.2000. National Comprehensive Cancer Network, Inc, 2000.
2. Maschmeyer G: Interventional antimicrobial therapy in febrile neutropenic patients. Diagn Microbiol Infect Dis 34:205-212, 1999.
3. Rolston KV: Expanding the options for risk-based therapy in febrile neutropenia. Diagn Microbiol Infect Dis 31:411-416, 1998.
4. Salazar R, Sola C, Maroto P, et al: Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 23:27-33, 1999.
5. Salutari P, Sica S, Laurenti L, et al: Incidence of sepsis after peripheral blood progenitor cells transplantation: Analysis of 86 consecutive hemato-oncological patients. Leuk Lymphoma 30:193-197, 1998.